| Trial | CAAA617A12402 |
|---|---|
| Cancer Type | Prostate Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of lutetium (177Lu) vipivotide tetraxetan in Adult Participants with Prostate Cancer |
| Trial | PACE-NODES |
|---|---|
| Cancer Type | Prostate Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | A phase III randomised trial of 5 fraction prostate SBRT versus 5 fraction prostate and pelvic nodal SBRT |
| Trial | Pivotal Boost |
|---|---|
| Cancer Type | Genitourinary and Prostate Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | A Phase III Randomised Controlled Trial of Prostate and Pelvis Versus Prostate Alone Radiotherapy With Or Without Prostate Boost |
| Trial | PSMAddition |
|---|---|
| Cancer Type | Prostate Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | An International Prospective Open-Label, Randomised, Phase 3 Study Comparing 177Lu-PSMA-617 In Combination With Standard of Care, Versus Standard Of Care Alone, In Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer |
| Trial | SABRE |
|---|---|
| Cancer Type | Prostate Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body RadiothErapy |
| Trial | UKGPC |
|---|---|
| Cancer Type | Genitourinary and Prostate Cancer |
| Hospital(s) | Altnagelvin Hospital, Antrim Hospital, and Ulster Hospital |
| Information | UK Genetics Prostate Cancer Study |
 |
Click Here to view Cancer Research UK trial summary |